Antibody assesement for COVID-19 prevalence two months after outbreak in the hot spot Region of Tirschenreuth / Bavaria
- Conditions
- J12.8B97.2Other viral pneumonia07.1, suspicion of COVID-19Coronavirus as the cause of diseases classified to other chapters
- Registration Number
- DRKS00021813
- Lead Sponsor
- Kliniken Nordoberpfalz AG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 2867
Inclusion Criteria
Employee of Kliniken Nordoberpfalz AG or Witron Group.
participants >= 18 years.
In writing, signed and dated Informed consent after verbal Information.
Exclusion Criteria
<18 years. Subject has not given consent for the clinical Trial.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method